UPDATE: Oppenheimer Downgrades Acasti Pharma (ACST) to Perform

August 31, 2020 4:11 PM EDT Send to a Friend
(Updated - August 31, 2020 4:14 PM EDT)

(updating comment)Oppenheimer analyst Leland Gershell downgraded Acasti Pharma (NASDAQ: ACST) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login